Interested? Contact Us
Teva, Intel to develop wearables to monitor Huntington's disease
(Reuters) - Teva Pharmaceutical Industries Ltd said on Thursday it was collaborating with Intel Corp to develop a wearable device to monitor patients with Huntington's, a fatal degenerative disease.
Stay Informed
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
